[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
AbbVie Inc (ABBV)
AbbVie to present Phase X ECLIPSE data for atogepant in migraine treatment at the European Headache Congress. Meanwhile, a 2023 NYT article resurfaces on how AbbVie allegedly gamed the patent system for Humira.
About AbbVie Inc
AbbVie Inc. is a global biopharmaceutical company.
AbbVie Inc uses the ticker $ABBV for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- AbbVie Inc (ABBV) trading volume is up XXXXX% from the previous week.
- AbbVie Inc (ABBV) social dominance is up XXXXX% from the previous month.
- AbbVie Inc (ABBV) engagements is up XXXXX% from the previous week.
Price: $XXX
Price 24-Hour Time-Series Raw Data
Despite positive news and dividend mentions, the stock is trading near a 52-week low, indicating that overvaluation concerns are currently outweighing positive developments, as suggested by the recent price action and social sentiment.
24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXXX on 2025-10-01
1-Year Low: $XXXXXX on 2025-01-22
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
AbbVie Inc (ABBV) is currently AltRank #165 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +155
X Month: XXX +100
X Months: XXX +120
X Year: XXX +84
1-Year High: XXXXX on 2025-05-14
1-Year Low: X on 2025-04-28
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-05-12
1-Year Low: XX on 2025-02-26
Engagements: XXXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXX +27%
X Month: XXXXXXXXX +19%
X Months: XXXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-01-26
1-Year Low: XXXXXX on 2025-11-09
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXXX X: XXXXXX YouTube: XXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXX -XXXX%
X Months: XXXXXX +56%
X Year: XXXXXXX +22%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-12-07
Mentions by network (24h): News: X Reddit: XXX TikTok: XXX X: XXXXX YouTube: XX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning AbbVie Inc (ABBV) in the last XX hours which is down XXXX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +21%
X Months: XXXXXX +270%
X Year: XXXXXX +149%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XXX on 2025-12-07
The most influential creators that mention AbbVie Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @abbvie | X | XXXXX | XX | XXXXXX |
| @ValueSense_io | X | XXXXXX | X | XXXXXX |
| @smithy05261244 | X | XXX | X | XXXXX |
| @WallStSai | X | XXXXX | X | XXXXX |
| @PCM_bio | X | XXXXX | X | XXXXX |
| @PrimeTrading_ | X | XXXXXX | X | XXXXX |
| @HOThomasWPhelps | X | XXXXX | X | XXXXX |
| @BowTiedBiotech | X | XXXXXX | X | XXXXX |
| @Michael16887539 | X | XXX | X | XXXXX |
| @yaireinhorn | XX | XXXXXX | X | XXXXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +3%
X Month: XX% +7%
X Months: XX% +6%
X Year: XX% +9%
1-Year High: XX% on 2025-07-04
1-Year Low: XX% on 2025-08-10
Most Supportive Themes:
- Positive Sentiment and All-Time Highs: (35%) The stock is experiencing strong investor confidence, reflected in positive sentiment and reaching all-time high prices.
- Product and Pipeline Updates: (25%) Positive trial results for upadacitinib and strategic acquisitions like Gilgamesh Pharmaceuticals are driving optimism.
- Dividend and Value: (15%) AbbVie is recognized as a strong dividend stock, attracting investors focused on value and income generation.
Most Critical Themes:
- Overvaluation Concerns: (10%) Some analyses suggest the stock may be overvalued, potentially leading to a future price correction.
- Competition and Market Dynamics: (5%) Competitive pressures from companies like Eli Lilly and Merck, and discussions about market dominance, are noted.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
X Week: XXXXX% +0.012%
X Month: XXXXX% +0.032%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-04
1-Year Low: XXXXX% on 2025-12-02
Market Dominance: XXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XX%
1-Year High: XXXXX% on 2025-03-11
1-Year Low: XXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$2.40%
X Month: $XXXXXXXXXXXXXXX -$1.10%
X Months: $XXXXXXXXXXXXXXX +$17%
X Year: $XXXXXXXXXXXXXXX +$28%
1-Year High: $XXXXXXXXXXXXXXX on 2025-10-01
1-Year Low: $XXXXXXXXXXXXXXX on 2025-01-22
Top AbbVie Inc News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"AbbVie to Present Phase X ECLIPSE Data Demonstrating Atogepant (AQUIPTA) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress"
News Link @PRNewswire 2025-12-11T16:00Z 228.6M followers, XXX engagements
"How a Drug Company Made $XXX Billion by Gaming the U.S. Patent System (Published 2023)"
News Link @nytimes 2023-01-28T16:25Z 228.6M followers, 21K engagements
Top AbbVie Inc Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NVO I looks to be finally crossing that XX month down trend that has acted as resistance. The recent uptick in the price action has been notable. I broke it down in this video: $LLY $LLYX $XBI $NVO $GPCR $VKTX $ABBV $ABVX $XLV $JNJ $ABBV $UNH $MRK $TMO $ABT $ISRG $AMGN $GILD $BSX $PFE $DHR $MDT $SYK $VRTX $MCK $CVS $BMY $HCA $REGN $ELV $CI $COR $IDXX $ZTS $BDX $EW $CAH $A"
X Link @HumbleMrktTimer 2025-12-11T17:44Z XX followers, XXX engagements
"$HIMS None of this is priced in yet or Hims would be at a new ATH above $72.👇 ✅ UK expansion ✅ Canada expansion ✅ Labs at-home ✅ Low testosterone treatments ✅ YourBio acquisition ✅ New $250M buyback $UNH $LLY $NVO $OSCR $SPY $XLV $JNJ $PFE $ABBV $MRK $CVS"
X Link @bullrunalpha 2025-12-11T17:44Z XXX followers, XXX engagements
"Biggest stock losers during the last hour $KO $LLY $BAC $AZN $ABBV $PEP $ABT $PM $NVO $JNJ $GEV $PDD $LYB $CIEN $WELL $VTRS $GME $SATS $QCOM $BLDR"
X Link @DenverMichaeI 2025-12-11T17:42Z XX followers, XX engagements
"'This is a great opportunity to get what we call a dividend growing stock': Nesbitt on Abbvie Inc"
YouTube Link @BNNBloomberg 2025-12-11T17:31Z 149K followers, XXX engagements